These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15813062)

  • 21. Introduction: the hemodynamic and vascular effects of angiotensin II: managing the consequences.
    Weber MA
    Am J Hypertens; 2002 Jan; 15(1 Pt 2):1S-2S. PubMed ID: 11824871
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renin-angiotensin-aldosterone system].
    Suzuki H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():153-6. PubMed ID: 15250285
    [No Abstract]   [Full Text] [Related]  

  • 23. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renin-angiotensin system--from Tigerstedt to Goldblatt to ACE inhibition and beyond.
    Atlas SA; Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):81-6. PubMed ID: 9520510
    [No Abstract]   [Full Text] [Related]  

  • 25. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.
    Nickenig G; Harrison DG
    Circulation; 2002 Jan; 105(3):393-6. PubMed ID: 11804998
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 27. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Angiotensin II antagonists: a promising pathway].
    Cohen-Solal A
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():10-1, 15. PubMed ID: 10949700
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.
    Shimamoto K; Miura T
    Intern Med; 2007; 46(16):1303-4. PubMed ID: 17704610
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiopathology of angiotensin II and vascular lesion].
    Russo F; Marci M; Raffa S
    Clin Ter; 1997 Nov; 148(11):537-41. PubMed ID: 9494256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The renin-angiotensin system and blood pressure regulation].
    Mann J
    Dtsch Med Wochenschr; 1994 Jul; 119(27):965-6. PubMed ID: 8026312
    [No Abstract]   [Full Text] [Related]  

  • 32. Renin angiotensin system antagonists and anesthesia.
    Colson P; Ryckwaert F; Coriat P
    Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease.
    Vaughan DE
    Eur Heart J; 1998 Jul; 19 Suppl G():G9-12. PubMed ID: 9717049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symposium on the etiology of hypertension--summarizing studies in 20th century. 5. Renin-angiotensin system and hypertension.
    Fujita T
    Intern Med; 2001 Feb; 40(2):156-8. PubMed ID: 11300153
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
    Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA
    Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in patients with acute coronary syndrome].
    Iino K; Ito H
    Nihon Rinsho; 2006 Apr; 64(4):734-41. PubMed ID: 16613192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulation of the renin angiotensin system in peripheral arterial disease.
    Hobbs SD; Thomas ME; Bradbury AW
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):573-82. PubMed ID: 15531190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tissue angiotensin II and its impact in the treatment of arterial hypertension].
    Escobar-Morreale HF; González Albarrán O; García Robles R
    Med Clin (Barc); 1997 Jan; 108(3):105-8. PubMed ID: 9064431
    [No Abstract]   [Full Text] [Related]  

  • 39. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.